David Gordon, MB ChB
2019
In 2019, David Gordon, MB ChB earned a total compensation of $1.4M as Chief Medical Officer at Aclaris Therapeutics, a 35% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $113,680 |
|---|---|
| Salary | $406,000 |
| Stock Awards | $843,592 |
| Other | $9,393 |
| Total | $1,372,665 |
ChB received $843.6K in stock awards, accounting for 61% of the total pay in 2019.
ChB also received $113.7K in non-equity incentive plan, $406K in salary and $9.4K in other compensation.
Rankings
In 2019, David Gordon, MB ChB's compensation ranked 7,775th out of 13,971 executives tracked by ExecPay. In other words, ChB earned more than 44.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,775 out of 13,971 | 44th |
Division Manufacturing | 3,049 out of 5,701 | 47th |
Major group Chemicals And Allied Products | 1,149 out of 2,200 | 48th |
Industry group Drugs | 982 out of 1,886 | 48th |
Industry Pharmaceutical Preparations | 730 out of 1,398 | 48th |
Source: SEC filing on April 23, 2020.
ChB's colleagues
We found three more compensation records of executives who worked with David Gordon, MB ChB at Aclaris Therapeutics in 2019.